Navigation Links
New treatment for Rheumatoid Arthritis

According to a new study,a common therapy for cancer may now provide relief for rheumatoid arthritis. Tumor growth in cancer patients is dependent on the growth of new blood vessels that cause cell proliferation. This ongoing angiogenesis supplies nutrients and oxygen to growing tumors and can be inhibited //by a substance called endostatin. The angiogenesis observed in tumor growth is nearly identical to that of patients with rheumatoid arthritis (RA), in which the proliferation of new blood vessels plays an important role in the disease.

Researchers in United States believe if endostatin can inhibit angiogenesis in cancer patients, it should be considered as a treatment therapy for RA as well. In a new study, researchers treated laboratory mice with endostatin for RA, and found the volume of new blood vessels, as well as inflammatory cells, was significantly decreased.


'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... ... the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for ... analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements ...
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
(Date:2/26/2017)... ... 26, 2017 , ... Functional imaging data supports improved cognition ... released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. , ... in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao et ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , ... and recognition opportunities as well as advocacy for the state and region‘s technology ... February 23. The Council's Innovation Forecast event highlights innovation throughout the region ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) today announced that ... Raymond James and Associates, 38 th Annual ... Orlando, FL. Cowen and Company ... March 7, 2017 in Boston, MA. ... in Miami, FL. Individuals ...
(Date:2/27/2017)... February 27, 2017 Leading Countries, Technologies and ... is expected to grow at a CAGR of 8.9% from 2016-2021 ... grow at a CAGR of 9.1% from 2016 to 2027. The ... ... will benefit you Read on to discover how you can ...
(Date:2/27/2017)... – December 2016 Revenues amounted to SEK 0.3 (0.1) ... Result after tax amounted to SEK -16.3 (-6.5) million, corresponding to ... flow from operating activities amounted to SEK -8.3 (-7.3) million ... Period full year 2016 ... to SEK -39.5 (-29.5) million Result after tax amounted to ...
Breaking Medicine Technology: